HAUGSTEN, Ellen Margrethe, Vigdis SØRENSEN, Michaela BOSÁKOVÁ, Gustavo Antonio de SOUZA, Pavel KREJČÍ, Antoni WIEDLOCHA and Jørgen WESCHE. Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport. Journal of Proteome Research. Washington: American Chemical Society, 2016, vol. 15, No 10, p. 3841-3855. ISSN 1535-3893. Available from: https://dx.doi.org/10.1021/acs.jproteome.6b00652.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport
Authors HAUGSTEN, Ellen Margrethe (578 Norway), Vigdis SØRENSEN (578 Norway), Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution), Gustavo Antonio de SOUZA (76 Brazil), Pavel KREJČÍ (203 Czech Republic, guarantor, belonging to the institution), Antoni WIEDLOCHA (578 Norway) and Jørgen WESCHE (578 Norway).
Edition Journal of Proteome Research, Washington, American Chemical Society, 2016, 1535-3893.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.268
RIV identification code RIV/00216224:14110/16:00091282
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1021/acs.jproteome.6b00652
UT WoS 000385054100035
Keywords in English FGFR4; FGF1; BioID; quantitative MS; confocal microscopy; three-dimensional structured illumination microscopy; endocytosis; clathrin; recycling compartment; trans-Golgi network
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Ing. Mgr. Věra Pospíšilíková, učo 9005. Changed: 21/11/2016 15:46.
Abstract
The fibroblast growth factor receptors (FGFRs) are important oncogenes promoting tumor progression in many types of cancer, such as breast, bladder, and lung cancer as well as multiple myeloma and rhabdomyosarcoma. However, little is known about how these receptors are internalized and down-regulated in cells. We have here applied proximity biotin labeling to identify proteins involved in FGFR4 signaling and trafficking. For this purpose we fused a mutated biotin ligase, BirA*, to the C-terminal tail of FGFR4 (FGFR4-BirA*) and the fusion protein was stably expressed in U2OS cells. Upon addition of biotin to these cells, proteins in proximity to the FGFR4-BirA* fusion protein became biotinylated and could be isolated and identified by quantitative mass spectrometry. We identified in total 291 proteins, including 80 proteins that were enriched in samples where the receptor was activated by the ligand (FGF1), among them several proteins previously found to be involved in FGFR signaling (e.g., FRS2, PLC gamma, RSK2 and NCK2). Interestingly, many of the identified proteins were implicated in endosomal transport, and by precise annotation we were able to trace the intracellular pathways of activated FGFR4. Validating the data by confocal and three-dimensional structured illumination microscopy analysis, we concluded that FGFR4 uses clathrin-mediated endocytosis for internalization and is further sorted from early endosomes to the recycling compartment and the trans-Golgi network. Depletion of cells for clathrin heavy chain led to accumulation of FGFR4 at the cell surface and increased levels of active FGFR4 and PLC?, while AKT and ERK signaling was diminished, demonstrating that functional clathrin-mediated endocytosis is required for proper FGFR4 signaling. Thus, this study reveals proteins and pathways involved in FGFR4 transport and signaling that provide possible targets and opportunities for therapeutic intervention in FGFR4 aberrant cancer.
Links
EE2.3.30.0009, research and development projectName: Zaměstnáním čerstvých absolventů doktorského studia k vědecké excelenci
PrintDisplayed: 6/5/2024 14:09